- Mixed-phenotype acute leukemia: suboptimal treatment when the 2008/2016 WHO classification is used
-
Pomerantz , Rodriguez-Rodriguez S, Demichelis-Gomez R, Barrera-Lumbreras G, Barrales-Benitez O, Lopez-Karpovitch X, Aguayo-Gonzalez A
- KMID: 2364313
- Blood Res.
- 2016 Dec;51(4):233-241.
- doi: 10.5045/br.2016.51.4.233
BACKGROUND: Different criteria have been used to diagnose mixed-phenotype acute leukemia (MPAL), which has impacted the number of individuals diagnosed with this pathology. Better outcomes have been reported when using... -
- CITED
-
- Close
- SHARE
-
- Close
- Induction-related mortality in adolescents and young adults with acute lymphoblastic leukemia in a resource-limited setting: do treatment-related complications create more impact than disease biology?
-
Inclan-Alarcon SI, Riviello-Goya S, Teran-De-la-Sancha K, Fierro-Angulo OM, Acosta-Medina AA, Demichelis-Gomez R, Bourlon C
- KMID: 2527494
- Blood Res.
- 2022 Mar;57(1):29-33.
- doi: 10.5045/br.2021.2021058
Background Acute lymphoblastic leukemia (ALL) is a malignant clonal bone marrow disorder with a high mortality rate during the initial therapy. This retrospective study aimed to describe and analyze the risk... -
- CITED
-
- Close
- SHARE
-
- Close
